Investor Guide – Key Points for Hims & Hers Health (HIMS) Shareholders

By Blake Campbell • Friday, June 27 10:00 • Permanent Link

With gains of 8.8%, Hims & Hers Health was one of the winners on Wall Street today. Its shares are now trading at $50.34 and have logged a 0.0% daily outperformance of the S&P 500. Don't join the feeding frenzy before checking some basic facts about this stock:

Hims & Hers Health has moved 129.2% over the last year, and the S&P 500 logged a change of 12.5%
HIMS has an average analyst rating of hold and is 3.72% away from its mean target price of $48.53 per share
Its trailing earnings per share (EPS) is $0.68
Hims & Hers Health has a trailing 12 month Price to Earnings (P/E) ratio of 74.0 while the S&P 500 average is 29.3
Its forward earnings per share (EPS) is $0.46 and its forward P/E ratio is 109.4
The company has a Price to Book (P/B) ratio of 20.49 in contrast to the S&P 500's average ratio of 4.74
Hims & Hers Health is part of the Health Care sector, which has an average P/E ratio of 22.94 and an average P/B of 3.19
HIMS has reported YOY quarterly earnings growth of 313.6% and gross profit margins of 0.8%
The company has a free cash flow of $213.45 Million, which refers to the total sum of all its inflows and outflows of cash over the last quarter
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.